3,182 hedge funds and large institutions have $196B invested in Pfizer in 2022 Q1 according to their latest regulatory filings, with 156 funds opening new positions, 1,374 increasing their positions, 1,338 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less capital invested

Capital invested by funds: $222B → $196B (-$25.8B)

15% less first-time investments, than exits

New positions opened: 156 | Existing positions closed: 183

34% less funds holding in top 10

Funds holding in top 10: 249165 (-84)

Holders
3,182
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
165
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.18B
Puts
$3.23B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
2026
$945K
2027
$942K
2028
$939K
2029
$937K
2030
$933K
2031
$933K
2032
$932K
2033
$932K
2034
$930K
2035
$930K
2036
$929K
2037
$929K
2038
$927K
2039
$927K
2040
$927K
2041
$926K
2042
$926K
2043
$923K
2044
$922K
2045
$921K
2046
$921K
2047
$920K
2048
$919K
2049
$916K
2050
$915K